tradingkey.logo
tradingkey.logo
Suchen

TELA Bio Inc

TELA
Zur Watchlist hinzufügen
0.706USD
-0.034-4.65%
Handelsschluss 06/26, 16:00ETKurse um 15 Minuten verzögert
27.91MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über TELA Bio Inc Unternehmen

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Inc Informationen

BörsenkürzelTELA
Name des UnternehmensTELA Bio Inc
IPO-datumNov 08, 2019
CEOKoblish (Antony)
Anzahl der mitarbeiter209
WertpapierartOrdinary Share
GeschäftsjahresendeNov 08
Addresse1 Great Valley Parkway, Suite 24
StadtMALVERN
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl19355
Telefon14843202930
Websitehttps://www.telabio.com/
BörsenkürzelTELA
IPO-datumNov 08, 2019
CEOKoblish (Antony)

Führungskräfte von TELA Bio Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+55.91%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von TELA Bio Inc?

Die fünf größten Anteilseigner von TELA Bio Inc sind: Mr. Antony Koblish

Wie viele Institutionen halten Anteile an TELA Bio Inc (TELA)?

Mit Stand vom 2026Q1 halten 163 Institutionen Anteile an TELA Bio Inc, mit einem Gesamtmarktwert von etwa 32.85M, was 73.39% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -6147477.00 gestiegen.

Was ist die größte Einnahmequelle von TELA Bio Inc?

Am 2026Q1 erzielte das Geschäft mit OviTex für TELA Bio Inc den höchsten Umsatz in Höhe von 51.22M, was 63.81% des Gesamtumsatzes entspricht.
KeyAI